XML 102 R77.htm IDEA: XBRL DOCUMENT v3.25.3
Schedule of measurement of the fair value and inputs at grant date (Details) - $ / shares
12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]    
Fair value at grant date (weighted average) $ 5.25 $ 13.92
Exercise price at grant date (weighted average) $ 6.50 $ 0.032
Expected volatility (weighted average) 144.00% 61.80%
Expected terms (years) (weighted average) 7 years 4 years
Expected dividend (weighted average)
Risk-free interest rate (weighted average) 4.33% 4.50%